PTC Therapeutics, Inc. (PTCT)
70.36
-1.11
(-1.55%)
USD |
NASDAQ |
May 18, 12:03
PTC Therapeutics Research and Development Expense (Quarterly) : 100.87M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 153.96M |
| Keros Therapeutics, Inc. | 16.10M |
| Insmed, Inc. | 209.48M |
| Madrigal Pharmaceuticals, Inc. | 108.31M |
| Protagonist Therapeutics, Inc. | 46.74M |